Showing results (111-120 of 2,922) with videos related to

Sort By:
Pageof 293
Parasite Immunology|April 28, 2020
Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double-edged, but adjustable weaponMarwa A Hasby Saad, Noha El-Anwar
Parasite Immunology|May 14, 2020
A portrait of the immune response to proliferative kidney disease (PKD) in rainbow troutChristyn Bailey, Jason W Holland, Christopher J Secombes, et al.
Parasite Immunology|January 7, 1998
Non-specific binding of IgG1 to Heligmosomoides polygyrus: adult worm homogenate superantigen is a target for immunoglobulin-induced inhibitionM Robinson, T R Gustad, M R Erickson, et al.
Parasite Immunology|April 16, 2020
Arginase and its mechanisms in Leishmania persistenceGabriela Pessenda, João Santana da Silva
Parasite Immunology|August 10, 2021
Immune mechanisms of Texel sheep to adult and egg stages of Haemonchus contortusAndrew R Weaver, Javier J Garza, Scott P Greiner, et al.
Parasite Immunology|April 20, 2020
Combinatorial Tim-3 and PD-1 activity sustains antigen-specific Th1 cell numbers during blood-stage malariaRebecca S Dookie, Ana Villegas-Mendez, Hans Kroeze, et al.
Parasite Immunology|January 1, 1992
In human malaria protective antibodies are directed mainly against the Lys-Glu ion pair within the Lys-Glu-Lys motif of the synthetic vaccine SPf 66A Molano, C Segura, F Guzman, et al.
Parasite Immunology|January 1, 1992
Cellular responses to phase fractions of Trypanosoma lewisiC M Ndarathi
Parasite Immunology|January 1, 1992
Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependentC M Lezama-Davila, D M Williams, G Gallagher, et al.
Parasite Immunology|January 1, 1992
Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66C L Rocha, L A Murillo, A L Mora, et al.
Pageof 293